Simple jQuery Dropdowns
Please use this identifier to cite or link to this item:
Title: The economic evaluation of human papillomavirus vaccination strategies against cervical cancer in women in Lao PDR: A mathematical modelling approach
Authors: Phetsavanh Chanthavilay
Daniel Reinharz
Mayfong Mayxay
Keokedthong Phongsavan
Donald E. Marsden
Lynne Moore
Lisa J. White
University of Health Sciences
Mahidol University
Universite Laval, Faculte de medecine
Institut de la Francophonie pour la Médecine Tropicale
Mahosot Hospital
University of Oxford
Setthathirath Hospital
Nuffield Department of Clinical Medicine
Keywords: Medicine
Issue Date: 22-Aug-2016
Citation: BMC Health Services Research. Vol.16, No.1 (2016)
Abstract: © 2016 The Author(s). Background: Cervical cancer, a preventable disease, is the third leading cause of cancer morbidity and mortality in the Lao People's Democratic Republic (Lao PDR). Since many cervical cancers are linked to human papilloma virus (HPV) infection, vaccination against this virus may lead to a reduction in these types of cancer. The study described here is the first to compare the cost-effectiveness of different HPV vaccination options in Lao PDR. Methods: A dynamic compartment model was created. The model included routine screening activities already in place, as well as theoretical interventions that included a 10-year old girl-only vaccination programme combined with/without a 10-year old boy vaccination programme and/or a catch-up component. The simulation was run over 100 years. In base case analyses, we assumed 70 % vaccination coverage with lifelong protection and 100 % efficacy against HPV types 16/18. The outcomes of interest were the incremental cost per Disability-Adjusted Life Year (DALY) averted. Results: In base case analyses, according to the WHO definition of cost-effectiveness thresholds, vaccinating 10-year-old girls was very cost-effective. Adding a catch-up vaccination element for females aged 11-25 years was also very cost-effective, costing 1559 international dollars (I$) per DALY averted. Increasing the age limit of the catch-up vaccination component to 75 years old showed that this remained a cost-effective option (I$ 5840 per DALY averted). Adding a vaccination programme for 10-year-old boys was not found to be cost-effective unless a short time simulation (30 years or less) was considered, along with a catch-up vaccination component for both males and females. Conclusions: Adding a catch-up female vaccination component is more attractive than adding a 10-year-old boy vaccination component.
ISSN: 14726963
Appears in Collections:Scopus 2016-2017

Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.